Kesimpta is a medicine for treating adults with relapsing forms of multiple sclerosis (MS), where the patient has flare\-ups (relapses) followed by periods with milder or no symptoms. It is used in patients with active disease, which means that they have relapses and/or signs of active inflammation on scans. Kesimpta contains the active substance ofatumumab.
Therapeutic Indication
Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features (see section 5\.1\).
Therapeutic Area (MeSH)
ATC Code
L04AA52
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressant
Active Substance (Summary)
INN / Common Names
EMA Name
Kesimpta
Medicine Name
Kesimpta
Aliases
N/ANo risk management plan link.
